Cargando…
Femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty: 2-year outcomes of endothelial cell loss and graft survival
PURPOSE: To assess 2-year endothelial cell loss and graft survival after femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty (FLS-DSEK). METHODS: In this prospective and noncomparative study carried out at Eye Hospital of Shandong First Medical University, 85 eyes (84 patient...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763781/ https://www.ncbi.nlm.nih.gov/pubmed/34463841 http://dx.doi.org/10.1007/s00417-021-05383-x |
_version_ | 1784634025175941120 |
---|---|
author | Wang, Ting Shi, Peiyan Li, Fengjie Gao, Hua Li, Suxia Liu, Tong Shi, Weiyun |
author_facet | Wang, Ting Shi, Peiyan Li, Fengjie Gao, Hua Li, Suxia Liu, Tong Shi, Weiyun |
author_sort | Wang, Ting |
collection | PubMed |
description | PURPOSE: To assess 2-year endothelial cell loss and graft survival after femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty (FLS-DSEK). METHODS: In this prospective and noncomparative study carried out at Eye Hospital of Shandong First Medical University, 85 eyes (84 patients) with endothelial dysfunction receiving FLS-DSEK (n=62, 75.9%) or FLS-DSEK combined with phacoemulsification cataract surgery and intraocular lens implantation (n=23, 27.1%) from 2013 through 2016 were included. The graft endothelial cell loss, endothelial graft thickness, visual acuity, and complications after surgery were evaluated. RESULTS: Thin endothelial grafts were all successfully prepared, with no occurrence of perforation. The rate of endothelial cell loss was 17.4%, 18.8%, 19.9%, and 26.7%, and the central graft thickness was 113±54 μm, 102±40 μm, 101±28 μm, and 96±23 μm at 3, 6, 12, and 24 months, respectively. The median best-corrected visual acuity was 0.4 logMAR (range, 0–2 logMAR) at 24 months, demonstrating a significant difference from that before surgery (2 logMAR; range, 0.2–3 logMAR) (T=187.5, P<.001). Partial graft dislocation was the most common postoperative complication, with an occurrence rate of 14% (n=12), and it was associated with an abnormal iris-lens diaphragm (r=.35, P<.001). The other complications included a high intraocular pressure (n=5, 6%), endothelial graft rejection (n=4, 5%), and pupillary block (n=1, 1%). Endothelial graft decompensation occurred in the two eyes, and 98% (n=83) of the grafts survived at 24 months. CONCLUSIONS: Data of the study suggest that the treatment using FLS-DSEK seems to be promising and might be considered a feasible choice in patients with endothelial dysfunction. TRIAL REGISTRATION: 1. Date of registration: 2021-02-18 2. Trial registration number: ChiCTR2100044091 3. Registration site: https://www.chictr.org.cn/ SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00417-021-05383-x. |
format | Online Article Text |
id | pubmed-8763781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-87637812022-01-31 Femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty: 2-year outcomes of endothelial cell loss and graft survival Wang, Ting Shi, Peiyan Li, Fengjie Gao, Hua Li, Suxia Liu, Tong Shi, Weiyun Graefes Arch Clin Exp Ophthalmol Cornea PURPOSE: To assess 2-year endothelial cell loss and graft survival after femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty (FLS-DSEK). METHODS: In this prospective and noncomparative study carried out at Eye Hospital of Shandong First Medical University, 85 eyes (84 patients) with endothelial dysfunction receiving FLS-DSEK (n=62, 75.9%) or FLS-DSEK combined with phacoemulsification cataract surgery and intraocular lens implantation (n=23, 27.1%) from 2013 through 2016 were included. The graft endothelial cell loss, endothelial graft thickness, visual acuity, and complications after surgery were evaluated. RESULTS: Thin endothelial grafts were all successfully prepared, with no occurrence of perforation. The rate of endothelial cell loss was 17.4%, 18.8%, 19.9%, and 26.7%, and the central graft thickness was 113±54 μm, 102±40 μm, 101±28 μm, and 96±23 μm at 3, 6, 12, and 24 months, respectively. The median best-corrected visual acuity was 0.4 logMAR (range, 0–2 logMAR) at 24 months, demonstrating a significant difference from that before surgery (2 logMAR; range, 0.2–3 logMAR) (T=187.5, P<.001). Partial graft dislocation was the most common postoperative complication, with an occurrence rate of 14% (n=12), and it was associated with an abnormal iris-lens diaphragm (r=.35, P<.001). The other complications included a high intraocular pressure (n=5, 6%), endothelial graft rejection (n=4, 5%), and pupillary block (n=1, 1%). Endothelial graft decompensation occurred in the two eyes, and 98% (n=83) of the grafts survived at 24 months. CONCLUSIONS: Data of the study suggest that the treatment using FLS-DSEK seems to be promising and might be considered a feasible choice in patients with endothelial dysfunction. TRIAL REGISTRATION: 1. Date of registration: 2021-02-18 2. Trial registration number: ChiCTR2100044091 3. Registration site: https://www.chictr.org.cn/ SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00417-021-05383-x. Springer Berlin Heidelberg 2021-08-31 2022 /pmc/articles/PMC8763781/ /pubmed/34463841 http://dx.doi.org/10.1007/s00417-021-05383-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Cornea Wang, Ting Shi, Peiyan Li, Fengjie Gao, Hua Li, Suxia Liu, Tong Shi, Weiyun Femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty: 2-year outcomes of endothelial cell loss and graft survival |
title | Femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty: 2-year outcomes of endothelial cell loss and graft survival |
title_full | Femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty: 2-year outcomes of endothelial cell loss and graft survival |
title_fullStr | Femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty: 2-year outcomes of endothelial cell loss and graft survival |
title_full_unstemmed | Femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty: 2-year outcomes of endothelial cell loss and graft survival |
title_short | Femtosecond laser semi-assisted Descemet stripping endothelial keratoplasty: 2-year outcomes of endothelial cell loss and graft survival |
title_sort | femtosecond laser semi-assisted descemet stripping endothelial keratoplasty: 2-year outcomes of endothelial cell loss and graft survival |
topic | Cornea |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763781/ https://www.ncbi.nlm.nih.gov/pubmed/34463841 http://dx.doi.org/10.1007/s00417-021-05383-x |
work_keys_str_mv | AT wangting femtosecondlasersemiassisteddescemetstrippingendothelialkeratoplasty2yearoutcomesofendothelialcelllossandgraftsurvival AT shipeiyan femtosecondlasersemiassisteddescemetstrippingendothelialkeratoplasty2yearoutcomesofendothelialcelllossandgraftsurvival AT lifengjie femtosecondlasersemiassisteddescemetstrippingendothelialkeratoplasty2yearoutcomesofendothelialcelllossandgraftsurvival AT gaohua femtosecondlasersemiassisteddescemetstrippingendothelialkeratoplasty2yearoutcomesofendothelialcelllossandgraftsurvival AT lisuxia femtosecondlasersemiassisteddescemetstrippingendothelialkeratoplasty2yearoutcomesofendothelialcelllossandgraftsurvival AT liutong femtosecondlasersemiassisteddescemetstrippingendothelialkeratoplasty2yearoutcomesofendothelialcelllossandgraftsurvival AT shiweiyun femtosecondlasersemiassisteddescemetstrippingendothelialkeratoplasty2yearoutcomesofendothelialcelllossandgraftsurvival |